|
IT1199374B
(it)
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
ES2237809T3
(es)
*
|
1997-02-28 |
2005-08-01 |
Kaneka Corporation |
Medicina curativa para la enfermedad causada por infeccion de helicobacter.
|
|
EP1453837A4
(en)
*
|
2001-11-21 |
2007-11-07 |
Activbiotics Inc |
TARGETED THERAPEUTIC AGENTS AND USES THEREOF
|
|
US7078399B2
(en)
*
|
2001-12-13 |
2006-07-18 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
ES2385477T3
(es)
*
|
2002-11-05 |
2012-07-25 |
Fadim S.R.L. |
Liberación continua y controlada de rifaximina
|
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
KR101327635B1
(ko)
|
2005-08-11 |
2013-11-12 |
타간타 테라퓨틱스 인크. |
포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도
|
|
WO2007103448A2
(en)
|
2006-03-09 |
2007-09-13 |
Salix Pharmaceuticals, Inc. |
Rifaximin anti-rectal dysfunction preparation
|
|
DK2054066T3
(en)
|
2006-08-02 |
2015-06-08 |
Salix Pharmaceuticals Inc |
METHODS OF TREATMENT OF RADIATE ENTERITIS
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
KR101667534B1
(ko)
*
|
2006-09-22 |
2016-10-19 |
씨아이피엘에이 엘티디. |
리팍시민
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
ES2798253T3
(es)
|
2007-07-06 |
2020-12-10 |
Lupin Ltd |
Composiciones farmacéuticas de rifaximina
|
|
AU2008273699A1
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
BRPI0908864A2
(pt)
|
2008-02-25 |
2018-09-18 |
Salix Pharmaceuticals Ltd |
formas da rifaximina e usos das mesmas
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
US8309569B2
(en)
|
2008-02-26 |
2012-11-13 |
Salix Pharmaceuticals, Ltd. |
Methods for treating diarrhea-associated irritable bowel syndrome
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
EP2294012B1
(en)
|
2008-05-07 |
2014-07-09 |
Salix Pharmaceuticals, Ltd. |
Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease
|
|
US8524691B2
(en)
|
2008-08-13 |
2013-09-03 |
The Medicines Company |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
RU2011116400A
(ru)
|
2008-09-26 |
2012-11-10 |
Аска Фармасьютикал Ко., Лтд. (Jp) |
Средство для предотвращения и/или лечения функционального расстройства желудочно-кишечного тракта
|
|
US12285414B2
(en)
|
2008-10-02 |
2025-04-29 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
EP3628319B1
(en)
|
2008-10-02 |
2024-02-14 |
Salix Pharmaceuticals, Ltd. |
Treatment of hepatic encephalopathy using rifaximin
|
|
WO2010067072A1
(en)
|
2008-12-10 |
2010-06-17 |
Cipla Limited |
Rifaximin complexes
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
CN102548408A
(zh)
|
2009-06-02 |
2012-07-04 |
萨利克斯药品有限公司 |
治疗肝性脑病的方法
|
|
KR20120062897A
(ko)
|
2009-09-13 |
2012-06-14 |
샐릭스 파마슈티컬스 리미티드 |
과민성 장 증후군(ｉｂｓ)의 치료방법
|
|
CN113274355B
(zh)
|
2009-10-27 |
2023-05-30 |
鲁平有限公司 |
利福昔明固体分散体
|
|
WO2011061519A2
(en)
|
2009-11-23 |
2011-05-26 |
Cipla Limited |
Topical foam composition
|
|
EP2401282B2
(en)
|
2009-12-28 |
2017-01-04 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
AU2011218129A1
(en)
|
2010-02-18 |
2012-08-23 |
Board Of Regents Of The University Of Texas System |
Methods for treating infection
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
CA2800235C
(en)
|
2010-03-10 |
2018-10-16 |
Lupin Limited |
Rifaximin ready-to-use suspension
|
|
US20120077835A1
(en)
|
2010-07-12 |
2012-03-29 |
Salix Pharmaceuticals, Ltd. |
Formulations of rifaximin and uses thereof
|
|
WO2012035544A2
(en)
|
2010-09-13 |
2012-03-22 |
Sequent Scientific Ltd. |
A novel polymorphic form of rifaximin and process for its preparation
|
|
JP6076267B2
(ja)
|
2011-02-11 |
2017-02-08 |
サリックス ファーマスーティカルズ，リミテッド |
リファキシミンの形態およびその使用
|
|
EP2705042A1
(en)
|
2011-05-02 |
2014-03-12 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
*
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
|
PL2773205T3
(pl)
|
2011-11-02 |
2024-09-02 |
Salix Pharmaceuticals, Inc. |
Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
WO2014091432A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of rifaximin
|
|
CA2897758A1
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Rifaximin for use in the treating of vaginal infections
|
|
WO2014140995A2
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Method for diagnosing vaginal infections
|
|
MX374340B
(es)
|
2013-04-12 |
2025-03-06 |
Alfasigma Spa |
Administracion de farmacos antiinflamatorios no esteroidales y composiciones, metodos y sistemas relacionados.
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
EP2927235B1
(en)
|
2014-03-31 |
2017-02-08 |
Euticals S.P.A. |
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
|
|
WO2015159275A2
(en)
*
|
2014-04-19 |
2015-10-22 |
Granules India Limited |
An improved process for the preparation of rifamycin derivatives
|
|
EP3140313B1
(en)
|
2014-05-04 |
2020-02-26 |
Salix Pharmaceuticals, Inc. |
Ibs microbiota and uses thereof
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
KR102494049B1
(ko)
|
2016-09-30 |
2023-01-31 |
샐릭스 파마슈티컬스 인코포레이티드 |
리팍시민의 고체 분산물 형태
|
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
|
DK3645539T3
(da)
*
|
2017-06-26 |
2021-05-10 |
Biofer Spa |
Pyrido-imidazo-rifamycin-derivater som antibakterielt middel
|